TODAY'S NEWS

Sotorasib Subgroup Analysis of Phase II ...

The KRAS-specific inhibitor sotorasib achieved res...

---

FDA Grants Zanubrutinib Accelerated Appr...

On September 15, zanubrutinib (Brukinsa), a small-...

---

EPOV Mark Kris

Mark G. Kris, MD, FASCO, Chief of the Thoracic Onc...

---

Atezolizumab Reduces Risk of Disease Pro...

Atezolizumab given after chemotherapy to patients ...

---

Extended Follow-up of PALOMA-3 Supports ...

An updated analysis of the PALOMA-3 randomized, pl...

More News From Today

EDITORIALS & COMMENTARY

https://www.advancedpractitioner.com/issues/volume-11,-number-6-(aug-2020)/asco20-virtual-scientific-program-takeaways-for-the-advanced-practitioner.aspx

CAR T-cell therapy is rapidly emerging as a promising treatment for many hematologic malignancies...

---

Rare Myeloproliferative Neoplasm w/CSF3R

Cases of chronic neutrophilic leukemia (CNL) are extremely rare and easily missed...

---

Management of Carcinoid Syndrome

Diarrhea is often a presenting symptom in patients with neuroendocrine tumors...

---

APs: Collaborators in Radiation Oncology

Advanced practitioners, including physician assistants and nurse practitioners, are medical professionals with...

---

Axicabtagene Ciloleucel: CAR T-Cell Therapy

Axicabtagene ciloleucel (axi-cel) is an anti-CD19 CAR T-cell therapy that has demonstrated efficacy...

More Editorials & Commentary

PREVIOUS HIGHLIGHTS

Gemcitabine/Eribulin in Cisplatin-Inelig...

In the final analysis from a phase II California C...

---

Deintensified Chemoradiotherapy for HPV-...

In a phase II trial reported in the Journal of Cli...

---

USPSTF Recommendation on Risk Assessment...

As reported in JAMA, the U.S. Preventive Services ...

---

Incidence of HPV-Associated Head and Nec...

In a study by Mahal et al published in Cancer Epid...

---

Racial Reporting and Representation in O...

New research published by Loree et al in JAMA Onco...

More Highlights

LATEST TWEETS

What more can we say? 👇👇👇👇 #JADPROLive ht...

about 21 hours ago via web

---

Last opportunity to take advantage of great r...

about 1 days ago via web

---

RT @guiniga: I’m in, are you??? I’m not early...

about 1 days ago via web

---

The #earlybird deadline for #JADPROLive Virtu...

about 3 days ago via web

---

Just an example of the types of articles avai...

about 7 days ago via web

More Tweets